High-Quality Assays.
Data-Driven Results.
Quality Data
Peapod Bio’s high-throughput assay solutions will give you the confidence you need to make go/no-go decisions.
Rapid Turnaround
Achieve your milestones faster with a team dedicated towards advancing your research through responsive communication and rapid data delivery.
Innovative Technologies
Benefit from label-free and beyond label-free technologies to take your program one step closer to the clinic.
Peapod Bio leads the industry in rapid assay solutions for small molecule drug discovery
Peapod Bio’s team and innovative technologies rapidly deliver solutions for your small molecule and peptide assay development and high-throughput screening drug discovery programs. Our unique label-free technologies that utilize high-throughput, state-of-the-art MALDI mass spectrometry and orthogonal approaches that go beyond label-free ensure that you achieve your drug discovery goals. Peapod Bio partners with you to deliver high-quality results faster than any other CRO.
Peapod Bio Solutions
Assay
Development
High-Throughput
Screening
Affinity Selection
Mass Spectrometry
Small Molecule Libraries
Hot off the Press
-
SLAS Europe 2026
Meet with Peapod Bio at the SLAS Europe 2026 Conference and Exhibition! May 19-21, 2026 | Vienna, Austria Poster Presentation:Poly A Polymerase Associated Domain enzyme inhibitors using an innovative mass spectrometry platformWednesday, May 20 | 1:30 PM – 2:30 PM Local Time | Poster #: 1042-APoster Session A in Exhibition Hall BTo schedule a meeting…
-
Peapod Bio appoints Michael Scholle, MS, MBA to Board of Directors
Appointment brings over fifteen years as a CRO executive Peapod Bio, Inc, an industry leading contract research organization for small molecule assay development and high-throughput screening solutions, announced the appointment of Michael Scholle, MS, MBA, to its board of directors, effective immediately. Scholle brings over twenty-five years of experience in assay development and high-throughput screening…